Trgovina Voyager Therapeutics Inc - VYGR CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.11 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Voyager Therapeutics Inc ESG Risk Ratings
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
Predhodno. Zapri* | 12.7 |
Odpri* | 12.63 |
Enoletna sprememba* | 125.94% |
Dnevni razpon* | 12.63 - 12.99 |
Razpon 52 wk | 4.61-14.34 |
Povprečni obseg (10 dni) | 612.53K |
Povprečni obseg (3 meseci) | 10.10M |
Tržna kapitalizacija | 548.11M |
Razmerje P/E | 5.49 |
Število delnic v obtoku | 43.54M |
Prihodki | 190.73M |
EPS | 2.29 |
Dividenda (donosnost v %) | N/A |
Beta | 1.10 |
Datum naslednjega zaslužka | Aug 2, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Jun 8, 2023 | 12.70 | -0.05 | -0.39% | 12.75 | 13.11 | 12.61 |
Jun 7, 2023 | 12.55 | 0.05 | 0.40% | 12.50 | 12.58 | 12.03 |
Jun 6, 2023 | 12.51 | 0.89 | 7.66% | 11.62 | 12.59 | 11.62 |
Jun 5, 2023 | 11.66 | 0.33 | 2.91% | 11.33 | 12.10 | 11.33 |
Jun 2, 2023 | 11.29 | -0.37 | -3.17% | 11.66 | 11.67 | 11.29 |
Jun 1, 2023 | 11.68 | 0.55 | 4.94% | 11.13 | 11.86 | 11.13 |
May 31, 2023 | 11.29 | -0.11 | -0.96% | 11.40 | 11.93 | 11.09 |
May 30, 2023 | 11.67 | -0.37 | -3.07% | 12.04 | 12.21 | 11.23 |
May 26, 2023 | 12.01 | 0.23 | 1.95% | 11.78 | 12.22 | 11.76 |
May 25, 2023 | 11.88 | -1.08 | -8.33% | 12.96 | 12.96 | 11.74 |
May 24, 2023 | 13.03 | 0.81 | 6.63% | 12.22 | 13.17 | 12.01 |
May 23, 2023 | 12.33 | -0.73 | -5.59% | 13.06 | 13.27 | 11.89 |
May 22, 2023 | 13.80 | 0.74 | 5.67% | 13.06 | 14.28 | 12.91 |
May 19, 2023 | 13.10 | 0.89 | 7.29% | 12.21 | 13.38 | 12.21 |
May 18, 2023 | 12.20 | 0.47 | 4.01% | 11.73 | 12.28 | 11.48 |
May 17, 2023 | 11.95 | 0.69 | 6.13% | 11.26 | 12.09 | 10.91 |
May 16, 2023 | 11.31 | 1.15 | 11.32% | 10.16 | 11.39 | 10.01 |
May 15, 2023 | 10.36 | 0.10 | 0.97% | 10.26 | 10.42 | 9.97 |
May 12, 2023 | 10.40 | 0.54 | 5.48% | 9.86 | 10.78 | 9.76 |
May 11, 2023 | 9.84 | -0.12 | -1.20% | 9.96 | 10.18 | 9.56 |
Voyager Therapeutics Inc Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
Wednesday, August 2, 2023 | ||
Čas (UTC) (UTC) 20:00 | Država US
| Dogodek Q2 2023 Voyager Therapeutics Inc Earnings Release Q2 2023 Voyager Therapeutics Inc Earnings ReleaseForecast -Previous - |
Monday, November 6, 2023 | ||
Čas (UTC) (UTC) 13:30 | Država US
| Dogodek Q3 2023 Voyager Therapeutics Inc Earnings Release Q3 2023 Voyager Therapeutics Inc Earnings ReleaseForecast -Previous - |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 40.907 | 37.415 | 171.128 | 104.391 | 7.619 |
Prihodki | 40.907 | 37.415 | 171.128 | 104.391 | 7.619 |
Celotni odhodki iz poslovanja | 91.744 | 111.033 | 143.744 | 156.07 | 98.714 |
Celotna prodaja/splošni/upravni stroški Odhodki | 30.98 | 37.246 | 34.991 | 36.335 | 33.809 |
Raziskave in razvoj | 60.764 | 73.787 | 108.753 | 119.735 | 64.905 |
Prihodki iz poslovanja | -50.837 | -73.618 | 27.384 | -51.679 | -91.095 |
Prihodki (odhodki) od obresti, neto Neoperativni | 1.792 | -0.39 | 1.659 | 6.457 | 3.31 |
Drugo, neto | 2.653 | 2.811 | 7.698 | 1.625 | -0.683 |
Čisti dobiček pred obdavčitvijo | -46.392 | -71.197 | 36.741 | -43.597 | -88.468 |
Čisti dobiček po davkih | -46.408 | -71.197 | 36.741 | -43.597 | -88.288 |
Čisti dobiček pred dodatnimi postavkami | -46.408 | -71.197 | 36.741 | -43.597 | -88.288 |
Čisti dobiček | -46.408 | -71.197 | 36.741 | -43.597 | -88.288 |
Total Adjustments to Net Income | |||||
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -46.408 | -71.197 | 36.741 | -43.597 | -88.288 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -46.408 | -71.197 | 36.741 | -43.597 | -88.288 |
Popravljen čisti dobiček | -46.408 | -71.197 | 36.741 | -43.597 | -88.288 |
Popravljene ponderirane povprečne delnice | 38.3568 | 37.6689 | 37.3485 | 35.8983 | 32.0658 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -1.2099 | -1.89007 | 0.98373 | -1.21446 | -2.75334 |
Popravljen normalizirani dobiček na enoto čistega dobička | -1.20821 | -1.82105 | 0.98373 | -1.21446 | -2.75334 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Skupni prihodki | 150.48 | 40.907 | 41.086 | 0.712 | 0.658 |
Prihodki | 150.48 | 40.907 | 41.086 | 0.712 | 0.658 |
Celotni odhodki iz poslovanja | 27.596 | 91.744 | 26.644 | 20.079 | 22.008 |
Celotna prodaja/splošni/upravni stroški Odhodki | 9.028 | 30.98 | 7.307 | 7.552 | 7.659 |
Raziskave in razvoj | 18.568 | 60.764 | 19.337 | 12.527 | 14.349 |
Prihodki iz poslovanja | 122.884 | -50.837 | 14.442 | -19.367 | -21.35 |
Prihodki (odhodki) od obresti, neto Neoperativni | 1.864 | 1.792 | 0.545 | 0.219 | 0.031 |
Drugo, neto | 2.653 | 2.637 | 0.061 | 0 | |
Čisti dobiček pred obdavčitvijo | 124.748 | -46.392 | 17.624 | -19.087 | -21.319 |
Čisti dobiček po davkih | 124.044 | -46.408 | 17.624 | -19.087 | -21.319 |
Čisti dobiček pred dodatnimi postavkami | 124.044 | -46.408 | 17.624 | -19.087 | -21.319 |
Čisti dobiček | 124.044 | -46.408 | 17.624 | -19.087 | -21.319 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 124.044 | -46.408 | 17.624 | -19.087 | -21.319 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 124.044 | -46.408 | 17.624 | -19.087 | -21.319 |
Popravljen čisti dobiček | 124.044 | -46.408 | 17.624 | -19.087 | -21.319 |
Popravljene ponderirane povprečne delnice | 42.1613 | 38.3568 | 39.5704 | 38.2984 | 38.0494 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 2.94213 | -1.2099 | 0.44538 | -0.49838 | -0.5603 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | 2.94213 | -1.20821 | 0.44538 | -0.54799 | -0.50773 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 124.499 | 136.698 | 197.769 | 304.659 | 162.481 |
Denarna sredstva in kratkoročne naložbe | 118.848 | 132.539 | 181.138 | 281.533 | 155.806 |
Denarna sredstva in ustrezniki | 98.959 | 117.433 | 104.44 | 86.042 | 46.859 |
Kratkoročne naložbe | 19.889 | 15.106 | 76.698 | 195.491 | 108.947 |
Celotne terjatve, neto | 0.639 | 0.748 | 8.107 | 18.972 | 0.201 |
Prepaid Expenses | 0.779 | 1.71 | 3.133 | 2.202 | 5.114 |
Other Current Assets, Total | 4.233 | 1.701 | 5.391 | 1.952 | 1.36 |
Total Assets | 159.356 | 193.855 | 261.584 | 354.76 | 177.029 |
Property/Plant/Equipment, Total - Net | 33.342 | 55.378 | 61.499 | 46.458 | 12.771 |
Property/Plant/Equipment, Total - Gross | 50.549 | 71.291 | 73.069 | 54.115 | 17.878 |
Accumulated Depreciation, Total | -17.207 | -15.913 | -11.57 | -7.657 | -5.107 |
Long Term Investments | 0 | 1.92 | 0.628 | ||
Other Long Term Assets, Total | 1.515 | 1.779 | 2.316 | 1.723 | 1.149 |
Total Current Liabilities | 72.591 | 50.981 | 26.766 | 76.012 | 31.673 |
Accounts Payable | 2.566 | 0.574 | 0.634 | 4.07 | 1.038 |
Accrued Expenses | 10.648 | 19.799 | 18.403 | 24.709 | 9.788 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 59.377 | 30.608 | 7.729 | 47.233 | 20.847 |
Total Liabilities | 100.336 | 98.8 | 107.264 | 255.248 | 130.583 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 27.745 | 47.819 | 80.498 | 179.236 | 98.91 |
Total Equity | 59.02 | 95.055 | 154.32 | 99.512 | 46.446 |
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Common Stock | 0.038 | 0.038 | 0.037 | 0.037 | 0.032 |
Additional Paid-In Capital | 452.713 | 442.259 | 430.324 | 412.227 | 315.598 |
Retained Earnings (Accumulated Deficit) | -393.512 | -347.104 | -275.907 | -312.648 | -269.051 |
Other Equity, Total | -0.219 | -0.138 | -0.134 | -0.104 | -0.133 |
Total Liabilities & Shareholders’ Equity | 159.356 | 193.855 | 261.584 | 354.76 | 177.029 |
Total Common Shares Outstanding | 38.6139 | 37.9184 | 37.368 | 36.8651 | 32.3649 |
Accounts Receivable - Trade, Net | 0.257 | 0.732 | 8.012 | 18.496 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 302.625 | 124.499 | 146.942 | 151.628 | 170.651 |
Denarna sredstva in kratkoročne naložbe | 273.314 | 118.848 | 131.638 | 148.056 | 166.833 |
Denarna sredstva in ustrezniki | 268.321 | 98.959 | 96.86 | 78.329 | 131.873 |
Kratkoročne naložbe | 4.993 | 19.889 | 34.778 | 69.727 | 34.96 |
Celotne terjatve, neto | 25.328 | 0.257 | 10.225 | 0.151 | 0.206 |
Accounts Receivable - Trade, Net | 25.328 | 0.257 | 10.225 | 0.151 | 0.206 |
Prepaid Expenses | 3.983 | 5.394 | 5.079 | 3.121 | 3.612 |
Total Assets | 336.294 | 159.356 | 182.48 | 188.605 | 224.182 |
Property/Plant/Equipment, Total - Net | 32.154 | 33.342 | 34.023 | 35.462 | 51.752 |
Other Long Term Assets, Total | 1.515 | 1.515 | 1.515 | 1.515 | 1.779 |
Total Current Liabilities | 19.939 | 72.591 | 73.242 | 97.932 | 101.677 |
Accounts Payable | 3.698 | 2.566 | 1.337 | 1.218 | 1.2 |
Accrued Expenses | 10.561 | 10.648 | 15.275 | 9.711 | 13.483 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 5.68 | 59.377 | 56.63 | 87.003 | 86.994 |
Total Liabilities | 119.333 | 100.336 | 102.657 | 128.553 | 148.251 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 99.394 | 27.745 | 29.415 | 30.621 | 46.574 |
Total Equity | 216.961 | 59.02 | 79.823 | 60.052 | 75.931 |
Common Stock | 0.043 | 0.038 | 0.038 | 0.038 | 0.038 |
Additional Paid-In Capital | 486.518 | 452.713 | 450.008 | 447.888 | 444.539 |
Retained Earnings (Accumulated Deficit) | -269.468 | -393.512 | -369.886 | -387.51 | -368.423 |
Other Equity, Total | -0.132 | -0.219 | -0.337 | -0.364 | -0.223 |
Total Liabilities & Shareholders’ Equity | 336.294 | 159.356 | 182.48 | 188.605 | 224.182 |
Total Common Shares Outstanding | 43.4359 | 38.6139 | 38.5203 | 38.4393 | 38.242 |
Other Current Assets, Total | 0.3 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -46.408 | -71.197 | 36.741 | -43.597 | -88.288 |
Denarna sredstva iz poslovanja | -12.509 | -53.525 | -96.716 | 48.666 | -15.887 |
Denarna sredstva iz poslovanja | 6.191 | 5.165 | 3.817 | 2.765 | 2.117 |
Nedenarne postavke | 7.237 | 9.213 | 7.263 | 11.06 | 14.582 |
Spremembe v obratnem kapitalu | 20.471 | 3.294 | -144.537 | 78.438 | 55.702 |
Denarna sredstva pri naložbenju | -7.339 | 65.906 | 112.995 | -90.477 | 26.467 |
Kapitalski izdatki | -2.491 | -1.609 | -12.097 | -7.718 | -4.305 |
Celotne druge postavke denarnih tokov pri naložbenju | -4.848 | 67.515 | 125.092 | -82.759 | 30.772 |
Denarna sredstva pri financiranju | 1.11 | 0.612 | 3.163 | 80.994 | 4.749 |
Izdaja (odplačilo) delnic, neto | 1.11 | 0.612 | 3.163 | 80.994 | 4.749 |
Neto sprememba denarnih sredstev | -18.738 | 12.993 | 19.442 | 39.183 | 15.329 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 124.044 | -46.408 | -22.782 | -40.406 | -21.319 |
Cash From Operating Activities | 123.565 | -12.509 | -0.265 | 15.941 | 34.426 |
Cash From Operating Activities | 1.075 | 6.191 | 5.357 | 4.016 | 2.812 |
Non-Cash Items | 2.585 | 7.237 | 4.507 | 2.342 | 2.34 |
Changes in Working Capital | -4.139 | 20.471 | 12.653 | 49.989 | 50.593 |
Cash From Investing Activities | 14.491 | -7.339 | -21.406 | -56.128 | -19.998 |
Capital Expenditures | -0.509 | -2.491 | -1.558 | -1.28 | -0.038 |
Other Investing Cash Flow Items, Total | 15 | -4.848 | -19.848 | -54.848 | -19.96 |
Cash From Financing Activities | 31.306 | 1.11 | 0.834 | 0.819 | 0.012 |
Issuance (Retirement) of Stock, Net | 31.306 | 1.11 | 0.834 | 0.819 | 0.012 |
Net Change in Cash | 169.362 | -18.738 | -20.837 | -39.368 | 14.44 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
Neurocrine Biosciences Inc | Corporation | 19.6973 | 8575316 | 4395588 | 2023-02-23 | LOW |
EcoR1 Capital, LLC | Hedge Fund | 8.8468 | 3851507 | 0 | 2023-03-31 | LOW |
Armistice Capital LLC | Hedge Fund | 8.0945 | 3524000 | 128000 | 2023-03-31 | HIGH |
Third Rock Ventures, LLC | Venture Capital | 7.5147 | 3271556 | 86265 | 2023-04-10 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.5128 | 1964680 | 9508 | 2023-03-31 | LOW |
Millennium Management LLC | Hedge Fund | 2.6704 | 1162553 | 883899 | 2023-03-31 | HIGH |
T. Rowe Price Associates, Inc. | Investment Advisor | 2.013 | 876365 | 129444 | 2023-03-31 | LOW |
Farallon Capital Management, L.L.C. | Hedge Fund | 1.8307 | 797000 | 797000 | 2023-03-31 | MED |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 1.7052 | 742355 | 73617 | 2023-03-31 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.6302 | 709702 | -33693 | 2023-03-31 | LOW |
D. E. Shaw & Co., L.P. | Hedge Fund | 1.4436 | 628472 | -60228 | 2023-03-31 | LOW |
Federated Hermes MDTA LLC | Investment Advisor/Hedge Fund | 1.3911 | 605618 | -41 | 2023-03-31 | HIGH |
Susquehanna International Group, LLP | Investment Advisor | 0.7391 | 321783 | 182684 | 2023-03-31 | HIGH |
JPMorgan Asset Management U.K. Limited | Investment Advisor/Hedge Fund | 0.7335 | 319322 | -2456 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.6277 | 273255 | 517 | 2023-03-31 | LOW |
Fiduciary Trust Company | Bank and Trust | 0.5795 | 252303 | 3774 | 2023-03-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.528 | 229847 | 89036 | 2023-03-31 | LOW |
Erste Asset Management GmbH | Investment Advisor | 0.4339 | 188900 | 0 | 2023-03-31 | LOW |
Jane Street Capital, L.L.C. | Research Firm | 0.3972 | 172916 | 147847 | 2023-03-31 | HIGH |
Renaissance Technologies LLC | Hedge Fund | 0.3039 | 132300 | 13000 | 2023-03-31 | HIGH |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group535K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$113M+
Mesečni obseg naložb
$64M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Voyager Therapeutics Inc Company profile
O družbi Voyager Therapeutics Inc
Voyager Therapeutics, Inc. je podjetje na klinični stopnji genskega zdravljenja, ki se osredotoča na razvoj zdravil za bolnike s hudimi nevrološkimi boleznimi. Podjetje pripravlja programe za hude nevrološke indikacije, vključno s Huntingtonovo boleznijo, monogeno obliko amiotrofične lateralne skleroze (ALS) in boleznimi, povezanimi s tau, vključno z Alzheimerjevo boleznijo, frontotemporalno demenco (FTD) in progresivno supranuklearno paralizo (PSP). Njegova linija je osredotočena tudi na razvoj genskih terapij z uporabo kapsid AAV (TRACER) in vektoriziranih protiteles. Osredotoča se na identifikacijo kapsid AAV, ki so zunanje lupine virusnih beljakovin, v katerih je zaprt genski material virusnega tovora. Družba razvija vektorizirana protitelesa, vključno s spojinami vektoriziranih protiteles, ki so sestavljene iz genoma virusnega vektorja, ki kodira približno eno ali več protiteles, ki ciljajo in se vežejo na beljakovino tau.
Industry: | Biotechnology & Medical Research (NEC) |
64 Sidney Street
CAMBRIDGE
MASSACHUSETTS 02139
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 535.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com